AU Patent

AU2020276619A1 — Compositions comprising ephedrine or an ephedrine salt and methods of making and using same

Assigned to Nexus Pharmaceuticals Inc · Expires 2021-12-16 · 4y expired

What this patent protects

The present disclosure provides compositions comprising ephedrine sulfate ready for immediate use in a clinical setting, and methods of making and using same.

USPTO Abstract

The present disclosure provides compositions comprising ephedrine sulfate ready for immediate use in a clinical setting, and methods of making and using same.

Drugs covered by this patent

Patent Metadata

Patent number
AU2020276619A1
Jurisdiction
AU
Classification
—
Expires
2021-12-16
Drug substance claim
No
Drug product claim
No
Assignee
Nexus Pharmaceuticals Inc
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.